z-logo
Premium
Severe vemurafenib‐induced photosensitivity in a 6‐year‐old boy
Author(s) -
Jew Olivia S.,
Provini Lauren E.,
Treat James R.
Publication year - 2018
Publication title -
pediatric dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.542
H-Index - 73
eISSN - 1525-1470
pISSN - 0736-8046
DOI - 10.1111/pde.13720
Subject(s) - vemurafenib , medicine , dermatology , sunburn , photosensitivity , adverse effect , basal cell , keratosis , cancer research , melanoma , metastatic melanoma , physics , quantum mechanics
Vemurafenib, a selective BRAF kinase inhibitor, has been found to induce several cutaneous adverse effects, ranging from a keratosis pilaris‐like reaction to squamous cell carcinoma. While photosensitivity has been well described as one of these manifestations, we report a case of a 6‐year‐old boy on vemurafenib who developed a severe blistering sunburn after only two 30‐minute episodes of sun exposure. A brief review of other common cutaneous adverse effects of vemurafenib is also provided.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here